Skip to main content
LISATA THERAPEUTICS, INC. logo

LISATA THERAPEUTICS, INC. — Investor Relations & Filings

Ticker · LSTA ISIN · US1280583022 LEI · 5493002287F62M3EGQ04 US Manufacturing
Filings indexed 1,093 across all filing types
Latest filing 2010-06-28 Capital/Financing Update
Country US United States of America
Listing US LSTA

About LISATA THERAPEUTICS, INC.

https://www.lisata.com/

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Recent filings

Filing Released Lang Actions
424B5 Filing
Capital/Financing Update Classification · 100% confidence The document is a prospectus supplement and accompanying prospectus for a securities offering by NeoStem, Inc. It details the terms of the offering, including the number of units, pricing, warrants, use of proceeds, risk factors, and other related information. The document is filed pursuant to Rule 424(b)(5), which is a SEC rule related to prospectus supplements for securities offerings. This type of document is a capital markets offering document, specifically a prospectus supplement related to a financing transaction. It is not a financial report, earnings release, management discussion, or any other type of corporate filing listed. Therefore, the correct classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains detailed offering terms, confirming it is not merely an announcement or a brief notice.
2010-06-28 English
8-K Filing
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes the company's entry into a material definitive agreement related to a securities placement agent agreement and securities purchase agreements, detailing the terms of a financing transaction including the sale of common stock and warrants. It also includes a press release about the offering and legal opinions related to the issuance. There are no financial statements or detailed financial performance data presented, so it is not an Annual Report (10-K) or Interim Report (IR). The document focuses on a financing transaction and capital raising activity. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is sufficient and contains substantive details about the financing event, not just an announcement of a report, so it is not RPA or RNS. Confidence is high given the clear description of the financing transaction and related agreements.
2010-06-28 English
8-K Filing
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The content includes regulatory approval updates for a subsidiary's manufacturing facility and a warrant grant to an executive. There are no financial statements or detailed financial analysis present. The document is not an annual or quarterly report, nor is it a transcript or presentation. It is a regulatory filing reporting material events as required by the SEC. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is 5487 characters, which is consistent with a typical 8-K filing. Confidence is high due to the clear identification of the form and content type.
2010-06-18 English
4 Filing
Director's Dealing
2010-06-18 English
4 Filing
Director's Dealing
2010-06-11 English
4 Filing
Director's Dealing
2010-06-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.